Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IBI362 in Overweight or Obesity Subjects
Clinical trial NCT04440345 · COMPLETED
Trial details
- NCT number
- NCT04440345
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-16
- Primary completion
- 2021-06-16
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.